|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advaxis Inc., of Princeton, N.J., completed its preclinical toxicology study of Lovaxin C for treatment of cervical, head and neck cancers. The results from the study of the Listeria Cancer Vaccine will allow Advaxis to start a Phase I/II study in cervical cancer patients.
Aptuit Inc., of Greenwich, Conn., said it will acquire Almedica International Inc., of Allendale, N.J., for an undisclosed cash consideration. Aptuit, which focuses on streamlining and supporting the drug development technology, plans to merge Almedica with the Quintiles Early Development and Packaging business units, as part of an acquisition announced July 19 and expected to close Sept. 30. ...